Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Patient Smartphone Ownership and Interest in Mobile Apps to Monitor Symptoms of Mental Health Conditions: A Survey in Four Geographically Distinct Psychiatric Clinics
- J. Torous, S. Chan, +6 authors M. Keshavan
- Medicine
- JMIR mental health
- 23 December 2014
Background Despite growing interest in mobile mental health and utilization of smartphone technology to monitor psychiatric symptoms, there remains a lack of knowledge both regarding patient… Expand
A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
- J. Barbee, T. Thompson, +5 authors R. Shelton
- Psychology, Medicine
- The Journal of clinical psychiatry
- 22 February 2011
BACKGROUND
Previous reports have suggested that lamotrigine is effective as an antidepressant augmentation agent in patients with treatment-resistant unipolar depression. This study is the largest… Expand
Aripiprazole augmentation in treatment-resistant depression.
- J. Barbee, E. Conrad, Nowal J Jamhour
- Psychology, Medicine
- Annals of clinical psychiatry : official journal…
- 1 October 2004
BACKGROUND
Evidence is accumulating to support the use of atypical neuroleptics as adjunctive treatment for refractory mood disorders, although there are currently no published data on the efficacy… Expand
Psychiatry Consultation During Disaster Preparedness: Hurricane Gustav
- E. Conrad, Kimberly M Lavigne
- Medicine
- Southern medical journal
- 1 January 2013
ObjectivesLittle is known about patient populations that remain during or after the mandatory evacuation of a city and use hospital services. This study sought to characterize the population that… Expand
The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder.
- J. Barbee, E. Conrad, Nowal J Jamhour
- Psychology, Medicine
- The Journal of clinical psychiatry
- 1 July 2004
BACKGROUND
Many questions remain regarding the use of atypical neuroleptics as antidepressant augmentation agents. To date, there have been no reports in the literature regarding the effectiveness of… Expand
The therapeutic potential of escitalopram in the treatment of panic disorder
- M. Townsend, E. Conrad
- Medicine
- Neuropsychiatric disease and treatment
- 1 December 2007
Panic disorder is a chronic and disabling condition that is often accompanied by other psychiatric and medical conditions. The serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine… Expand
Update on anesthesia considerations for electroconvulsive therapy.
- C. Mayo, A. Kaye, E. Conrad, A. Baluch, E. Frost
- Medicine
- Middle East journal of anaesthesiology
- 1 February 2010
Depression is diagnosed in 14 million Americans every year, and pharmacotherapy is the standard treatment. However, in approximately 50% of patients, pharmacology intervention does not resolve… Expand
Assessment of Psychiatric Symptoms at a Level I Trauma Center Surgery Follow-up Clinic: A Preliminary Report
- E. Conrad, T. Hansel, Nicholas G. Pejic, J. Constans
- Medicine
- The American surgeon
- 1 May 2013
At Level I trauma centers, psychiatric consultation is readily available to inpatient surgical services. This study sought to characterize the psychiatric symptoms present in the surgical follow-up… Expand
Childhood Trauma Exposure and Gun Violence Risk Factors Among Victims of Gun Violence
- Rachel Wamser-Nanney, John T. Nanney, E. Conrad, J. Constans
- Psychology, Medicine
- Psychological trauma : theory, research, practice…
- 2019
Objective: Gun violence is a serious public health concern, yet risk factors for gun violence involvement remain understudied. Childhood trauma exposure, such as domestic violence (DV) and community… Expand